Kentucky Medicaid managers would face limits on favoring opioids over physician-prescribed nonopioid pain drugs, with federal approval requested if officials find it necessary.
For acute or chronic pain, Medicaid managers could not favor an opioid over a physician-prescribed nonopioid drug or set stricter controls for clinically appropriate nonopioids than for opioid or narcotic drugs.
If federal approval is needed to protect federal funds or follow federal law, the cabinet or department must request it within 90 days after this section takes effect. It may delay only the parts needing approval until approval is granted.
The Department for Medicaid Services, its contracted managed care organizations, and the state pharmacy benefit manager may not deny coverage of a prescribed nonopioid drug in favor of an opioid or apply stricter controls to it than to clinically appropriate opioid or narcotic drugs. The rule covers the Department for Medicaid Services, managed care organizations under contract with the department, and the state pharmacy benefit manager contracted by the department. A licensed physician must prescribe the nonopioid drug to treat acute or chronic pain. The control limit compares clinically appropriate drugs.
If federal approval is needed to protect federal funds or comply with federal law, the cabinet or department must request it and may delay the parts that need it. The request and any delay apply to the parts of Section 1 that need federal authorization or approval. The Cabinet for Health and Family Services or the Department for Medicaid Services must determine that federal approval is needed to prevent loss of federal funds or comply with federal law. Only provisions for which approval is needed may be delayed. The 90-day deadline runs from this section’s effective date. Any permitted delay lasts until the needed approval is granted.
No hearings or votes scheduled.